-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
-
- Our Pipeline Development
-
Nu.Q® Cancer
We are developing a range of blood-based assays with potential applications beyond cancer detection.
-
Capture-Seq™
We have developed Capture-Seq™, a novel liquid biopsy method designed to isolate and analyze pure circulating tumor-derived DNA (ctDNA) from blood samples.
Plasma H3.1 nucleosomes as biomarkers of infection, inflammation and organ failure
- Share
- Tweet
- Share on Facebook
- Share
Poster titled: Plasma H3.1 nucleosomes as biomarkers of infection, inflammation and organ failure
Daan F.L. Filippini, Michael Jiang, Lina Kramer, Tom van der Poll, Olaf Cremer, Teddy Tun Win Hla, Andrew Retter, Lieuwe D.J. Bos
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields